Current Cancer Drug Targets
Title:Preface
Volume: 20 Issue: 1
Author(s): Ruiwen Zhang
Affiliation:
Export Options
About this article
Cite this article as:
Zhang Ruiwen , Preface, Current Cancer Drug Targets 2020; 20 (1) . https://dx.doi.org/10.2174/156800962001200127161234
DOI https://dx.doi.org/10.2174/156800962001200127161234 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Determinants of the Cardiometabolic Phenotype
Endocrine, Metabolic & Immune Disorders - Drug Targets Copeptin in Preeclampsia Development
Current Women`s Health Reviews Lycopene Protects Liver Against Ulcerative Colitis
Current Drug Therapy Cell Adhesion Molecules and Cadmium
Current Chemical Biology Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Metaboloepigenetics: The Emerging Network in Stem Cell Homeostasis Regulation
Current Stem Cell Research & Therapy Calreticulin in the Heart: From Embryological Development to Cardiac Pathology.
Current Molecular Medicine Vasopressin in Liver Disease – Should We Turn On or Off?
Current Clinical Pharmacology Dysfunction of Cellular Transporters and Predisposition to Diabetic Nephropathy
Current Diabetes Reviews Retinal Nerve Fiber Layer Thickness is Associated with Episodic Memory Deficit in Mild Cognitive Impairment Patients
Current Alzheimer Research Purines as Neurotransmitters and Neuromodulators in Blood Vessels
Current Vascular Pharmacology Primary Aldosteronism: Novel Insights
Current Hypertension Reviews Synthetic Dihydropyridines as Novel Antiacanthamoebic Agents
Medicinal Chemistry Subject Index to Volume 2
Current Pharmacogenomics Endothelial Dysfunction and Coronary Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Recent Advances and Perspectives in the Silver-catalyzed Multi-component Reactions
Current Organic Chemistry Subject Index to Volume 4
Current Drug Metabolism Pharmacological Interventions on Asymmetric Dimethylarginine, a Clinical Marker of Vascular Disease
Current Medicinal Chemistry The Treatment of Autoimmune Hepatitis
Current Clinical Pharmacology How Effective are the Lipid Modifying Medicines at Preventing Coronary Heart Disease in Patients with Type 2 Diabetes?
Vascular Disease Prevention (Discontinued)